<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045341">
  <TermName>cladribine</TermName>
  <TermPronunciation>(KLAD-rih-been)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat hairy cell leukemia. It is also being studied in the treatment of other types of cancer. Cladribine damages the cell’s DNA and may kill cancer cells. It is a type of antimetabolite.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730897" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cladribine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730896" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cladribina&quot;" language="es" id="_4"/>
  <SpanishTermName>cladribina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para tratar la leucemia de células pilosas. También está en estudio para el tratamiento de otros tipos de cáncer. La cladribina daña el ADN de las células y suele destruir células cancerosas. Es un tipo de antimetabolito.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2016-12-12</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000785724" url="/about-cancer/treatment/drugs/cladribine">Cladribine</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
